JERRY C. KNIGHT, is the Founder of “YOU’RE NOT ALONE PROSTATE CANCER SELF HELP SUPPORT GROUP” of Jackson, MS.  He is a native “Mississippian,” an advocate for Prostate Cancer, Salesman, EMS Driver, and a former Small Business Owner.  As a 5-year Prostate Cancer Survivor, Jerry regularly and passionately shares his cancer journey with male organizations, men’s church groups, and at targeted health and wellness events.  He and his wife Connie currently reside in Ridgeland, MS. They are the proud parents of 7 children, 19 grandchildren, and 2 great grandchildren. Jerry aspires to effectively impact men on all levels, by raising awareness focusing primarily on the African American Community.

Lee H. Moultrie II is a prostate cancer survivor (8 years) and a retired U.S. Air Force veteran. He served from 1994 during the Desert Storm and Desert Shield era. Lee is the PHEN Ambassador in North Charleston, South Carolina for the state of South Carolina. He is also the Ambassador for the Hollings Cancer Center at the Medical University of South Carolina and the University of Florida Health—Proton Therapy Institute in Jacksonville, Florida. Both institutions are National Cancer Institute-designated cancer centers.

Further, he is a member of the Medical University of South Carolina – Hollings Cancer Center on the Diversity, Equity, and Inclusion Committee as well as a committee member and past executive board member of the South Carolina Cancer Alliance.

A few other healthcare advocacy committees that Lee is part of include the Patient and Family Experience of Roper Hospital, the Patient and Family Advisory Council of the Veterans Administration Hospital in Charleston, South Carolina, and the In Our DNA Project of the Medical University of South Carolina. Further, Lee Moultrie is a Legislative Ambassador volunteering with the American Cancer Society and Zero Cancer.

In 2007, he was nominated for the Jefferson Award for Community Service and appeared in the 2008 Aetna African American History Calendar, which had the theme Health Literacy: A Dose of Understanding. Lee’s perspectives are included in several publications, such as a paper published in the Journal of the South Carolina Medical Association in 2006 before he was diagnosed with prostate cancer. The paper’s title is Prostate Cancer Disparities in South Carolina: Two Generations Talking From a Male’s Perspective. By 2015, Lee was diagnosed with prostate cancer.

Lee is also the CEO and Founder of www.choosetoliveformen.org. He is a regular contributor to the local newspaper with his health perspectives published in the Letters to the Editor section. Lastly, Lee was one of several participants in the very first PHEN Summit in Washington, DC in 2005.

Jill Daigneault, PhD is a Medical Science Liaison at Sumitomo Pharma America and holds a Ph.D. in Cancer Biology from The University of Michigan. Following graduation, she completed a postdoctoral fellowship at the University of Colorado – Anschutz Medical Campus. Prior to joining Sumitomo, Dr. Daigneault was a scientific program manager at the International Association for the Study of Lung Cancer. She has been in industry for the last 2.5 years.

Jay Jhaveri, MD, MPH currently serves as Director, Medical Affairs – Oncology at Bayer Pharmaceuticals. He performed a general surgery residency at the New York Medical College, a urology residency at the University of California, Irvine, and research and clinical fellowships at Weill Cornell, New York Presbyterian Hospital and the Henry Ford Health Systems, Vattikuti Urology Institute in prostate cancer outcomes research and minimally invasive urologic surgery, respectively. He also holds a Masters of Public Health in epidemiology and biostatistics and is very well published in several top-tier journals including the Journal of Clinical Oncology, Journal of Urology, and the Oncologist.

Phillip Davis, MD, is a nuclear medicine physician based in Charleston, South Carolina who has been employed full-time by Blue Earth Diagnostics (BED) since May 2019. Prior to joining the development and medical teams at BED, Dr. Davis spent 10 years working in the division of medical imaging and radiation medicine at the FDA in Silver Spring, Maryland. He recently served as the medical lead on the phase 3 trials of POSLUMA in the US, which culminated in our approval on May 25, 2023.

June M. Chan, Sc.D. is a Professor and Vice Chair for Education in the Department of Epidemiology & Biostatistics and she is also a Steven & Christine Burd-Safeway Distinguished Professor in the Department of Urology at the University of California, San Francisco. Professor Chan is a cancer epidemiologist, and her research focus includes health behaviors (e.g., diet, exercise, screening), social determinants, and cancer survivorship; understanding the biological effects of health behaviors on prostate cancer outcomes; and circulating and tissue biomarkers for prostate cancer prognosis.